Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $819.8200 (-1.14%) ($819.8200 - $833.8300) on Mon. Apr. 17, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.57% (three month average) | RSI | 51 | Latest Price | $819.8200(-1.14%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.2% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(49%) XLV(47%) DIA(35%) VYM(33%) IWD(32%) | Factors Impacting REGN price | REGN will decline at least -0.785% in a week (0% probabilities). VXX(-29%) VIXM(-22%) UUP(-4%) TBT(-4%) SMH(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.785% (StdDev 1.57%) | Hourly BBV | -1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $823.78(-0.48%) | 10 Day Moving Average | $824.11(-0.52%) | 20 Day Moving Average | $812.55(0.89%) | To recent high | -1.3% | To recent low | 14.5% | Market Cap | $86.924b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |